Martinez, CA, United States of America

Christopher J Macko

This inventor holds 1 USPTO granted patent. Top assignee: Bio-Rad Laboratories, Inc.. Active years: 1993.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christopher J Macko: Innovator in Clinical Analysis Technology

Introduction

Christopher J Macko is a notable inventor based in Martinez, California. He has made significant contributions to the field of clinical analysis technology. His innovative work has led to the development of a patented invention that enhances the efficiency of automated clinical analyzers.

Latest Patents

Macko holds a patent for a "Reagent receptacle and support rack for automated clinical analyzers." This invention features a reagent vessel with a puncturable and preferably self-sealing membrane. The support rack is designed with a rigid wall and retaining members that securely hold the vessel in place. This design provides structural support to the membrane while allowing access to its contents through holes in the wall.

Career Highlights

Christopher J Macko is currently employed at Bio-Rad Laboratories, Inc., a company renowned for its innovative solutions in life science research and clinical diagnostics. His work at Bio-Rad has allowed him to apply his expertise in developing advanced technologies that improve clinical analysis processes.

Collaborations

Macko has collaborated with notable colleagues, including Jordan S Honig and Richard B Edwards. These partnerships have contributed to the advancement of technologies in the clinical analysis field.

Conclusion

Christopher J Macko is a distinguished inventor whose work has significantly impacted the clinical analysis industry. His patented invention demonstrates his commitment to innovation and improving healthcare technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…